A Blend of Science & Software

Our Mission is to provide an incubator for therapeutics and devices that utilize trained Artificial Intelligence (AI) and Machine Learning (ML) to aid in diagnosis and decision making.

Investment

Identification and investment in high value pharmaceuticals and devices.

Market Focus

Market segment focus, but not limited to, Neuroscience (Parkinson's Disease) and Imaging (Contrast Agents).

Seed Capital

Provide Seed Capital and Co-Investment in Early-Stage Projects.

Intellectual Property

Identify and License in technologies from University and/or Government sponsored research.

Bring Ideas to Life

Support and encourage the development of AI/ML software to complement the clinical and commercial utility of the asset.

Support of Early-Stage Medical Ventures

Meritage Technologies Inc. will provide entrepreneurs with the essential support to establish a robust technical and business platform. The principals involved in the venture collectively offer over 50 years of expertise in pharmaceutical research, encompassing injectable, oral, and diagnostic medical products, business development, and start-up management. Furthermore, in addition to seed investment, the company maintains contacts providing contract services, including grant writing, oral and injectable manufacturing, regulatory affairs, and CMC consulting.

Why Choose Us?

We are well-experienced business professionals with younger minds.

Passion & Commitment
Honesty & Openness
Dedicated Team
Practical Approach

Our Management

Industry experience includes Abbott Laboratories, Lyphomed, Co-founder and President of Cary Pharmaceuticals, Co-Founder of Handa Pharmaceuticals.
Douglas D. Cary, Principal R.Ph, MBA
BA Marketing U of Iowa, MBA University of Maryland. Industry experience in field sales at GlaxoSmithKline, Co Founder, BOD Cary Pharmaceuticals and Co-Founder and Chief Operating Office of Handa Pharmaceuticals Inc.
Stephen D. Cary, Principal, BA Marketing

We provide management expertise and seed investment to de-risk select projects to advance human clinical trials and strategic partnerships.

Send us a message